Orion Group provided earnings guidance for the full year 2022. The company estimated that net sales in 2022 will be clearly higher than in 2021 (net sales in 2021 were EUR 1,041 million). Operating profit is estimated to be clearly higher than in 2021 (operating profit in 2021 was EUR 243 million).
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.78 EUR | +0.83% |
|
+4.77% | +6.37% |
07-01 | Orion, Merck & Co. Convert Agreement into Exclusive Global License to Opevesostat | MT |
07-01 | Orion Upgrades FY24 Outlook After Modifying Agreement with Merck & Co | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.37% | 6.24B | |
+56.86% | 823B | |
+44.56% | 641B | |
-6.57% | 352B | |
+17.32% | 324B | |
+9.94% | 301B | |
+15.23% | 241B | |
+1.27% | 223B | |
+12.80% | 218B | |
+7.98% | 167B |
- Stock Market
- Equities
- ORNBV Stock
- News Orion Oyj
- Orion Group Provides Earnings Guidance for the Full Year 2022